Loading...

STSS SHARPS TECHNOLOGY INC Investments/Divestments 8-K Filing

SHRP

STSS

SHARPS TECHNOLOGY INC

(STSS)

2024 8-K

Show Summary

Show Summary

Reverse Stock Split

Investor Meetings

Nasdaq Compliance

Public Offering

Nasdaq Compliance

Public Offering

Shareholder Voting

Warrant Approval

Delisting Notice

Public Offering

Bylaw Amendment

Annual Meeting Results

Bylaw Amendment

Press Release Issued

Stock Split Proposal

Press Release Issued

Securities Agreement

Amendment to Articles of In...

Supply Agreement with Steri...

Meeting Results

Investment Agreement

Investment Agreement

Correction and Warrant Indu...

Regulation FD Disclosure

Warrant Inducement Agreement

Regulation FD Disclosure

Agreements with Nephron SC ...

Cooperative Sales and Distr...

Resignation of Previous Ind...

Annual Meeting Approval

Asset Purchase Agreement wi...

Elimination of floor price ...

Departure of Directors

External Links:

Sharps Technology, Inc. has entered into a Supply Agreement with Stericare Solutions, LLC to sell 520 million units of 10ml PP Sologard syringes, with expected revenues in excess of $50M.

AI Assistant

SHARPS TECHNOLOGY INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.